Aneurysmal Subarachnoid Hemorrhage with a Poor-Grade Presentation
A 55-year-old smoker presents with a sudden severe headache and collapse. On arrival she is intubated, GCS 7 (E1 V1 M5), with equal pupils and no focal deficit. CT shows diffuse subarachnoid hemorrhage with intraventricular blood and hydrocephalus. CT angiography demonstrates a 7 mm anterior communicating artery aneurysm. She has a history of hypertension and takes aspirin for primary prevention. Blood pressure is 150/85 mmHg. The neurosurgeon is deciding between endovascular coiling and surgical clipping, and the family asks about prognosis.
1. How do you prioritize management in the first 24 hours, and what is the role of an external ventricular drain?
Read the worked answer
Priorities in the first 24 hours:
- Stabilize - airway and ventilation, avoid hypoxia and hypotension, maintain normocapnia, and control blood pressure to reduce rebleeding risk while preserving cerebral perfusion.
- Diagnose and secure the aneurysm - early treatment (within 24–72 hours) reduces rebleeding, which carries high mortality. The choice between coiling and clipping depends on aneurysm location, morphology, patient age, and local expertise; for an anterior communicating artery aneurysm, both are feasible.
- Manage hydrocephalus - intraventricular blood and hydrocephalus with a poor-grade presentation commonly require an external ventricular drain (EVD) for CSF diversion and ICP monitoring. An EVD can improve consciousness and is often placed early.
- Prevent and treat complications - nimodipine for vasospasm prophylaxis, seizure management, electrolyte and glucose control, and VTE prophylaxis once the aneurysm is secured.
- Rebleeding prevention - blood pressure control and early aneurysm treatment.
The EVD is both therapeutic (hydrocephalus) and diagnostic (ICP, CSF sampling). It should be placed with careful technique and managed with a standardized protocol to reduce infection.
2. How do you discuss prognosis with the family, and what factors influence outcome?
Read the worked answer
Discuss prognosis honestly and with uncertainty, using validated predictors rather than a single number.
Factors influencing outcome:
- Clinical grade - poor-grade (WFNS IV–V, Hunt and Hess IV–V) SAH has high mortality and disability, but a proportion of patients with reversible causes (hydrocephalus, seizures, sedation) can improve after CSF diversion and aneurysm treatment.
- Age and comorbidities - older age and smoking worsen outcome.
- Aneurysm treatment - early securing reduces rebleeding.
- Complications - vasospasm/delayed cerebral ischemia, hydrocephalus, rebleeding, and medical complications (sepsis, cardiac, respiratory) drive morbidity.
- Imaging - the amount of blood (modified Fisher grade) predicts vasospasm risk.
Explain that the first 24–72 hours are critical and that decisions may need to be revisited as her neurological status evolves. Emphasize shared decision-making, involve palliative care if appropriate, and document the discussion. Avoid giving a precise survival percentage; instead give a range and focus on what can be done.
3. What is your approach to blood pressure and to the aspirin she takes for primary prevention?
Read the worked answer
- Blood pressure - before the aneurysm is secured, aim to reduce the risk of rebleeding while maintaining cerebral perfusion. Common targets are systolic blood pressure around 140–160 mmHg (or mean arterial pressure tailored to the patient), using short-acting titratable agents (e.g., labetalol, nicardipine). Avoid hypotension. After securing the aneurysm, allow permissive hypertension to reduce delayed cerebral ischemia, unless there is a specific contraindication.
- Aspirin - aspirin for primary prevention is generally of limited benefit and increases bleeding risk; in the setting of acute SAH and pending neurosurgery, it should be withheld and its indication reviewed. If she has a genuine secondary prevention indication, discuss restarting after the aneurysm is secured and hemostasis is assured.
Document the rationale and coordinate with the treating team and family.